
During P2Y12 Antiplatelet Therapy, Treatment Of Anemia Was More Frequent Among PERIPHERAL Artery Disease Patients With Lower EGFR : The Euclid Trial
2020 at the American Society of Nephrology’s Kidney Week 2020 Reimagined virtual conference by Dr Judith Hsia et al from








